Haberkorn U - Search Results

1

Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Kowalski J, Henze M, Schuhmacher J, Mäcke HR, Hofmann M, Haberkorn U. Kowalski J, et al. Among authors: haberkorn u. Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8. doi: 10.1016/s1536-1632(03)00038-6. Mol Imaging Biol. 2003. PMID: 14499161

2

Chemotherapeutic management of head and neck malignancies with positron emission tomography.

Reisser C, Haberkorn U, Dimitrakopoulou-Strauss A, Seifert E, Strauss LG. Reisser C, et al. Among authors: haberkorn u. Arch Otolaryngol Head Neck Surg. 1995 Mar;121(3):272-6. doi: 10.1001/archotol.1995.01890030014003. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7873142

3

The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.

Reisser C, Haberkorn U, Strauss LG. Reisser C, et al. Among authors: haberkorn u. J Otolaryngol. 1993 Aug;22(4):231-8. J Otolaryngol. 1993. PMID: 8230373

4

[Diagnostic evaluation of the breast using PET: optimization of data acquisition and postprocessing].

Brix G, Henze M, Doll J, Lucht R, Zaers J, Trojan H, Knopp MV, Haberkorn U. Brix G, et al. Among authors: haberkorn u. Nuklearmedizin. 2000;39(3):62-6. Nuklearmedizin. 2000. PMID: 10834192 German.

5

Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.

Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, Peschke P, Kübler W, Debus J, Eisenhut M. Haberkorn U, et al. J Nucl Med. 2001 Feb;42(2):317-25. J Nucl Med. 2001. PMID: 11216532 Free article.

6

Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.

Schuhmacher J, Kaul S, Klivényi G, Junkermann H, Magener A, Henze M, Doll J, Haberkorn U, Amelung F, Bastert G. Schuhmacher J, et al. Among authors: haberkorn u. Cancer Res. 2001 May 1;61(9):3712-7. Cancer Res. 2001. PMID: 11325843 Clinical Trial.

7

PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.

Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, Mäcke HR, Hofmann M, Debus J, Haberkorn U. Henze M, et al. Among authors: haberkorn u. J Nucl Med. 2001 Jul;42(7):1053-6. J Nucl Med. 2001. PMID: 11438627 Free article.

8

Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.

Haberkorn U, Altmann A, Kamencic H, Morr I, Traut U, Henze M, Jiang S, Metz J, Kinscherf R. Haberkorn U, et al. Eur J Nucl Med. 2001 Nov;28(11):1690-6. doi: 10.1007/s002590100644. Eur J Nucl Med. 2001. PMID: 11702112

9

Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience.

Brix G, Henze M, Knopp MV, Lucht R, Doll J, Junkermann H, Hawighorst H, Haberkorn U. Brix G, et al. Among authors: haberkorn u. Eur Radiol. 2001;11(10):2058-70. doi: 10.1007/s003300100944. Eur Radiol. 2001. PMID: 11702142

10

Positron emission tomography (PET) of non-small cell lung cancer.

Haberkorn U. Haberkorn U. Lung Cancer. 2001 Dec;34 Suppl 2:S115-21. doi: 10.1016/s0169-5002(01)00351-8. Lung Cancer. 2001. PMID: 11720751 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters